DK1024794T3 - Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer - Google Patents

Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer

Info

Publication number
DK1024794T3
DK1024794T3 DK98952043T DK98952043T DK1024794T3 DK 1024794 T3 DK1024794 T3 DK 1024794T3 DK 98952043 T DK98952043 T DK 98952043T DK 98952043 T DK98952043 T DK 98952043T DK 1024794 T3 DK1024794 T3 DK 1024794T3
Authority
DK
Denmark
Prior art keywords
dry
pharmaceutical formulations
capsules
treatment
powdered pharmaceutical
Prior art date
Application number
DK98952043T
Other languages
Danish (da)
English (en)
Inventor
Steven T Horhota
Saim Said
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26741866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1024794(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1024794T3 publication Critical patent/DK1024794T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/02—Solvent extraction of solids
    • B01D11/0203—Solvent extraction of solids with a supercritical fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/02—Equipment for testing the apparatus

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98952043T 1997-10-14 1998-10-05 Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer DK1024794T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6209997P 1997-10-14 1997-10-14
US09/157,267 US6228394B1 (en) 1997-10-14 1998-09-21 Supercritical fluid extraction of mould lubricant from hard shell capsules
PCT/US1998/020815 WO1999018939A1 (en) 1997-10-14 1998-10-05 Methods of treating capsules and dry, powdered pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DK1024794T3 true DK1024794T3 (da) 2007-04-10

Family

ID=26741866

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98952043T DK1024794T3 (da) 1997-10-14 1998-10-05 Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer

Country Status (23)

Country Link
US (1) US6228394B1 (zh)
EP (1) EP1024794B1 (zh)
JP (1) JP2001519380A (zh)
KR (1) KR20010031097A (zh)
CN (1) CN1306420A (zh)
AT (1) ATE350019T1 (zh)
AU (1) AU753076B2 (zh)
BG (1) BG65169B1 (zh)
BR (1) BR9814818A (zh)
CA (1) CA2302276C (zh)
CY (1) CY1106033T1 (zh)
CZ (1) CZ299101B6 (zh)
DE (1) DE69836822T2 (zh)
DK (1) DK1024794T3 (zh)
EE (1) EE200000292A (zh)
ES (1) ES2281141T3 (zh)
HU (1) HUP0003990A3 (zh)
IL (1) IL134731A0 (zh)
NZ (1) NZ504394A (zh)
PL (1) PL195462B1 (zh)
PT (1) PT1024794E (zh)
TR (1) TR200001000T2 (zh)
WO (1) WO1999018939A1 (zh)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294194B1 (en) * 1997-10-14 2001-09-25 Boehringer Ingelheim Pharmaceuticals, Inc. Method for extraction and reaction using supercritical fluids
GB9804379D0 (en) * 1998-03-02 1998-04-22 Bradford Particle Design Ltd Method of particle formation
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
EP1292281B1 (de) * 2000-10-12 2004-09-08 Boehringer Ingelheim Pharma GmbH & Co.KG Neue tiotropium-haltige inhalationspulver
US6544282B1 (en) 2001-02-21 2003-04-08 Radiant Medical, Inc. Inhibition of platelet activation, aggregation and/or adhesion by hypothermia
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
US6923175B2 (en) 2002-03-20 2005-08-02 Mannkind Corporation Inhalation apparatus
US20030181749A1 (en) * 2002-03-21 2003-09-25 Kunzler Jay F. Supercritical fluid extraction of vitreoretinal silicone tamponades
JP2005523951A (ja) * 2002-04-23 2005-08-11 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド カルボマー中の残留有機溶媒の低減方法
AU2003228907A1 (en) * 2002-05-07 2003-11-11 Nektar Therapeutics Capsules for dry powder inhalers and methods of making and using same
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
WO2005018410A1 (de) * 2003-07-30 2005-03-03 BSH Bosch und Siemens Hausgeräte GmbH Verfahren zum betreiben eines gerätes mit wenigstens einem teilprogrammschritt 'trocknen'
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
EP1791542B1 (en) 2004-08-23 2015-05-20 Mannkind Corporation Diketopiperazine salts for drug delivery
DE102004060479A1 (de) * 2004-12-16 2006-06-29 Schaeffler Kg Verfahren und Vorrichtung zum Schmieren und Kühlen eines hochbelasteten Lagers
DE112006001898B4 (de) * 2005-07-21 2013-05-08 National Institute For Materials Science Vorrichtung zur Inhalation von Arzneimitteln
DK1928423T3 (en) 2005-09-14 2016-02-29 Mannkind Corp A method for drug formulation based on increasing the affinity of the active substances to the crystalline microparticle surfaces
RU2403059C2 (ru) 2006-02-22 2010-11-10 Маннкайнд Корпорейшн Способ улучшения фармацевтических свойств микрочастиц, содержащих дикетопиперазин и активный агент
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
TWI611818B (zh) 2008-06-13 2018-01-21 曼凱公司 用於藥物傳輸之乾粉吸入器及系統
JP5479465B2 (ja) 2008-06-20 2014-04-23 マンカインド コーポレイション 吸入努力をリアルタイムにプロファイルする対話式機器および方法
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
WO2010105094A1 (en) * 2009-03-11 2010-09-16 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US8734845B2 (en) 2009-06-12 2014-05-27 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
KR20130117755A (ko) 2010-06-21 2013-10-28 맨카인드 코포레이션 건조 분말 약물 운반 시스템 및 방법
BR112013025395B1 (pt) 2011-04-01 2022-02-01 Mannkind Corporation Embalagem de bolha e método de fabricação de uma embalagem de bolhas
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
CA2852536A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
CN108057154B (zh) 2012-07-12 2021-04-16 曼金德公司 干粉药物输送系统和方法
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
CN108578372B (zh) 2013-03-15 2021-07-06 曼金德公司 微晶二酮哌嗪组合物以及方法
JP6491658B2 (ja) 2013-07-18 2019-03-27 マンカインド コーポレイション 熱安定性乾燥粉末医薬組成物及び方法
CN105517607A (zh) 2013-08-05 2016-04-20 曼金德公司 吹入设备和方法
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN108451920A (zh) * 2018-03-14 2018-08-28 绍兴康可胶囊有限公司 一种吸雾式胶囊及其制备方法
CN109289249A (zh) * 2018-12-08 2019-02-01 内蒙合成化工研究所 一种高能推进剂中增塑剂和安定剂的回收方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61155265A (ja) 1984-12-26 1986-07-14 住友重機械工業株式会社 超臨界流体により成形体中のバインダ−を除去する方法
JPH0363232A (ja) 1989-07-10 1991-03-19 Syntex Usa Inc 溶剤抽出方法
DK0412053T3 (da) 1989-07-31 1995-07-10 Ciba Geigy Ag Ekstraktion af organiske opløsningsmidler fra formede genstande med superkritiske fluida og gasser nær det kritiske punkt
US5254335A (en) * 1990-10-10 1993-10-19 Clairol Incorporated Hair conditioning compounds containing reactive nonionic surfactants and isothiuronium compounds and method of use
US5198115A (en) * 1991-07-09 1993-03-30 Analytical Bio-Chemistry Laboratories, Inc. Integrated instrument for supercritical fluid sample extraction, sample separation and concentration
US5481058A (en) 1994-01-07 1996-01-02 Minnesota Mining And Manufacturing Company Supercritical fluid extraction involving hydrofluoroalkanes
US5641510A (en) 1994-07-01 1997-06-24 Genentech, Inc. Method for treating capsules used for drug storage

Also Published As

Publication number Publication date
AU9783898A (en) 1999-05-03
DE69836822T2 (de) 2007-04-26
ATE350019T1 (de) 2007-01-15
WO1999018939A1 (en) 1999-04-22
CZ20001365A3 (cs) 2000-09-13
DE69836822D1 (de) 2007-02-15
PL342650A1 (en) 2001-06-18
BR9814818A (pt) 2000-10-03
EP1024794B1 (en) 2007-01-03
BG104317A (en) 2000-12-29
CZ299101B6 (cs) 2008-04-23
CY1106033T1 (el) 2011-04-06
JP2001519380A (ja) 2001-10-23
EE200000292A (et) 2001-08-15
CA2302276A1 (en) 1999-04-22
PL195462B1 (pl) 2007-09-28
EP1024794A1 (en) 2000-08-09
HUP0003990A2 (en) 2001-03-28
IL134731A0 (en) 2001-04-30
PT1024794E (pt) 2007-02-28
BG65169B1 (bg) 2007-05-31
HUP0003990A3 (en) 2001-04-28
NZ504394A (en) 2002-12-20
CA2302276C (en) 2008-02-05
WO1999018939A9 (en) 1999-06-03
US6228394B1 (en) 2001-05-08
ES2281141T3 (es) 2007-09-16
AU753076B2 (en) 2002-10-10
KR20010031097A (ko) 2001-04-16
CN1306420A (zh) 2001-08-01
TR200001000T2 (tr) 2000-11-21

Similar Documents

Publication Publication Date Title
DK1024794T3 (da) Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer
IS6560A (is) Lyfjasamsetning fyrir meðhöndlun á bráðum, þrálátum sársauka og/eða taugakerfissársauka og mígreni
YU23102A (sh) Jedinjenja za lečenje ishemije
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
EA200100872A1 (ru) Композиция валдекоксиба
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
NO308029B1 (no) Inhibitorer av <beta>-amyloidproteinproduksjon og farmasøytisk preparat inneholdende disse
MA27880A1 (fr) Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
HU229456B1 (en) Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
AR024564A1 (es) Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico
ATE282607T1 (de) Tryptase-inhibitoren
SE9904581D0 (sv) A novel helicobacter pylori-binding substance and use thereof
IS6675A (is) Amínóalkoxýbensóýl-bensófúran eða bensóþíófenafleiður, aðferð til framleiðslu þeirra og samsetningar sem innihalda þær
TR200100637T2 (tr) Yeni doğal ürün türevleri
NO20033318D0 (no) 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav
NO20013787D0 (no) Soyaekstrakt som inneholder lipider, fremgangsmåte for dets fremstilling og farmasöytiske og kosmetiske blandinger
DK0544760T3 (da) Farmaceutiske præparater indeholdende 5-difluormethoxy-2- (3,4-dimethoxy-2-pyridyl)methylsulfinyl benzimidazol og at anti-helicobactermiddel til behandling af gastrointestinale lidelser
NO993784L (no) Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene
WO2003072053A3 (en) Compounds for treatment of copper overload
DK1017667T3 (da) 2-amino-6-methyl-7-acetyltetralin og farmaceutiske præparater til forebyggelse og terapeutisk behandling af inflammatoriske og/eller autoimmune patalogier
ES495459A0 (es) Procedimiento para la obtencion de nuevos carbamatos
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
MXPA05004121A (es) Metodos para tratar la enfermedad de ojo reseco con lantibioticos.